United Orthopedic Corporation (TPEX: 4129)

Market Cap	8.93B
Revenue (ttm)	4.47B
Net Income (ttm)	453.71M
Shares Out	96.29M
EPS (ttm)	4.73
PE Ratio	19.61
Forward PE	15.83
Dividend	4.00 (4.32%)
Ex-Dividend Date	Jul 18, 2024

Volume	143,908
Open	94.10
Previous Close	93.70
Day's Range	92.80 - 94.10
52-Week Range	82.40 - 114.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 28, 2025

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2023, United Orthopedic's revenue was 3.93 billion, an increase of 24.02% compared to the previous year's 3.17 billion. Earnings were 379.62 million, an increase of 71.36%.